Outcomes of Patients With Venoarterial Extracorporeal Membrane Oxygenation

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04039594

Enrollment

500

Registered

2019-07-31

Start date

2019-08-01

Completion date

2025-07-31

Last updated

2019-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest, Cardiogenic Shock

Keywords

extracorporeal life support, extracorporeal membrane oxygenation, cardiogenic shock, cardiac arrest

Brief summary

Venoarterial extracorporeal membrane oxygenation (VA ECMO)-also referred to as extracorporeal life support-is a form of temporary mechanical circulatory support and simultaneous extracorporeal gas exchange. The objective of this observational, cohort study is to evaluate the short-term and long-term outcomes of patients with VA ECMO.

Interventions

DEVICEVA ECMO

VA ECMO for cardiopulmonary support

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

Patients receiving VA ECMO for cardiopulmonary support

Exclusion criteria

Refusal of consent

Design outcomes

Primary

Measure	Time frame
All-cause mortality	30 days

Secondary

Measure	Time frame	Description
All-cause mortality	365 days	—
Rate of successful weaning from ECMO	30 days	—
ECMO-related complications	30 days	Bleeding requiring transfusion or surgery, stroke, sepsis, limb ischemia requiring intervention, system or cannula change
Other complications	30 days	Acute renal failure, ulcer bleeding, pneumonia, sepsis
Duration stay at ICU and hospital	365 days	—

Countries

China

Contacts

Primary ContactXiaotong Hou, MD., PhD.

xt.hou@ccmu.edu.cn8610 64456631

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026